- Home
- PBLS vs HAYW Comparison
PBLS vs HAYW Comparison
Compare PBLS & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBLS | HAYW |
|---|---|---|
| Founded | N/A | 1925 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | 2026 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PBLS | HAYW |
|---|---|---|
| Price | $38.91 | $14.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 347.7K | ★ 2.7M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $1,122,155,000.00 |
| Revenue This Year | N/A | $6.22 |
| Revenue Next Year | N/A | $5.96 |
| P/E Ratio | ★ N/A | $134.18 |
| Revenue Growth | N/A | ★ 6.71 |
| 52 Week Low | $25.56 | $12.93 |
| 52 Week High | $38.83 | $17.73 |
Technical Indicators
Market Signals| Indicator | PBLS | HAYW |
|---|---|---|
| Relative Strength Index (RSI) | 70.43 | 40.63 |
| Support Level | $26.42 | $14.12 |
| Resistance Level | N/A | $16.37 |
| Average True Range (ATR) | 2.56 | 0.40 |
| MACD | 0.27 | -0.09 |
| Stochastic Oscillator | 97.71 | 5.80 |
Price Performance
Historical ComparisonAbout PBLS Parabilis Medicines Inc. Common Stock
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.